Bank Hapoalim B.M. ("Hapoalim") will be the last and the largest of Israel’s non-controlled banks to hold its annual meeting in 2020. On the meeting agenda are compensation policy and compensation packages of the board [...]
Glass Lewis submitted comments to the Israel Justice Ministry as part of a public consultation on the matter of adapting corporate governance standards for a capital market with a greater number of non-controlled companies. You [...]
Israeli regulators have opened a public consultation to discuss the perceived need to adapt corporate governance standards applying to non-controlled companies in the context of a visibly changing capital market. For Israeli companies a nucleus [...]
Glass Lewis’ Policy Guidelines provide an overview of our approach to governance and proxy research. Updated guidelines are now available for the Netherlands, Germany, and Japan, and updates to other markets will be released soon. Current [...]
Glass Lewis’ Policy Guidelines provide an overview of our approach to governance and proxy research. Updated guidelines are now available for Denmark, Continental Europe, Finland, France, Greece, Italy, Norway, Poland, Russia, Spain, Sweden, and United Kingdom, and updates to other markets will be released soon. Current [...]
Glass Lewis’ Policy Guidelines provide an overview of our approach to governance and proxy research. Updated guidelines are now available for the United States, Canada, Israel, and Shareholder Initiatives, and updates to other markets will be [...]
TEVA PHARMACEUTICALS Tel Aviv Stock Exchange / NYSE: TEVA Meeting Date: 7/31/2014 Teva Pharmaceuticals' upcoming annual meeting will be rocked by an unprecedented "Vote [...]
Israel becomes the latest market to approve legislation to require shareholder consent of compensation to companies’ senior executives. As reported last month in Globes, an Israeli financial newspaper, the Israeli Knesset passed an amendment to [...]